Entrada Therapeutics, Inc. (TRDA): Weighted Average Diluted Shares
41.37M
Year ended 2025-12-31
+9.8%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 41.37M | +6.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 39.00M | +18.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 33.05M | +5.6% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | 31.29M | n/c | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | 6.27M | +467.1% | 2023-03-06, From 2021-01-01 |
| 2020-12-31 | 1.11M | n/a | 2022-03-15, From 2020-01-01 |